Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1

References

• FengM, PanY, KongR, ShuS. Therapy of primary liver cancer. Innovation. 2020;1:100032. doi:10.1016/j.xinn.2020.100032
   Web of Science ®Google Scholar
• LlovetJM, KelleyRK, VillanuevaA, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6. doi:10.1038/s41572-020-00240-333479224
   PubMed Web of Science ®Google Scholar
• YeungKT, YangJ. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017;11:28–39. doi:10.1002/1878-0261.1201728085222
   PubMed Web of Science ®Google Scholar
• NietoMA, HuangRY, JacksonRA, ThieryJP. EMT: 2016. Cell. 2016;166:21–45. doi:10.1016/j.cell.2016.06.02827368099
   PubMed Web of Science ®Google Scholar
• MarcucciF, StassiG, De MariaR. Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov. 2016;15:311–325. doi:10.1038/nrd.2015.1326822829
   PubMed Web of Science ®Google Scholar
• LamouilleS, XuJ, DerynckR. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–196. doi:10.1038/nrm375824556840
   PubMed Web of Science ®Google Scholar
• ZhangYY, KongLQ, ZhuXD, et al. CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway. Cancer Lett. 2018;429:29–40. doi:10.1016/j.canlet.2018.05.00429746931
   PubMed Web of Science ®Google Scholar
• YuCP, YuS, ShiL, et al. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1. Mol Med Rep. 2017;16:5181–5188. doi:10.3892/mmr.2017.722328849004
   PubMed Web of Science ®Google Scholar
• WangXF, LuWJ, ChenJY, et al. Studies on the chemical constituents of Ventilago leiocarpa Benth. Yao Xue Xue Bao. 1993;28:122–125. Chinese.8328280
   PubMedGoogle Scholar
• LiuY, LuGS, LuWJ, WangL, HuangZF, HuXX.  Effects of ventilagolin on the apoptosis of human hepatoma hepg2 cells and cytoskeletal protein F-actin (in Chinese). Zhong Guo Zhong Yi Ji Chu Yi Xue Za Zhi. 2017;23:791–794. Chinese.
   Google Scholar
• ChengDH, LiuY, WangL. Antitumor effects of ethanol extract from ventilago leiocarpa Benth on sarcoma 180 tumor-bearing mice and possible immune mechanism. Chin J Integr Med. 2021. doi:10.1007/s11655-021-3440-4
   Web of Science ®Google Scholar
• LiT, WangZ, HouYF, LiYY. Pim-3 regulates stemness of pancreatic cancer cells via activating STAT3 signaling pathway. J Cancer. 2017;8:1530–1541. doi:10.7150/jca.1862828775772
   PubMed Web of Science ®Google Scholar
• LiJQ, YangX, ZhouXM. PIM1 gene silencing inhibits proliferation and promotes apoptosis of human esophageal cancer cell line Eca-109. Cancer Biomark. 2017;18:149–154. doi:10.3233/CBM-16003827983525
   PubMed Web of Science ®Google Scholar
• MawasAS, AmatyaVJ, SuzukiR, KushitaniK, Mohi El-DinMM, TakeshimaY. PIM1 knockdown inhibits cell proliferation and invasion of mesothelioma cells. Int J Oncol. 2017;50:1029–1034. doi:10.3892/ijo.2017.386328197633
   PubMed Web of Science ®Google Scholar
• ZhaoB, LiuL, MaoJ, ZhangZ, WangQ, LiQ. PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis. Cell Death Dis. 2018;9:307. doi:10.1038/s41419-018-0348-929472550
   PubMed Web of Science ®Google Scholar
• GaoX, LiuX, LuY, et al. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer. 2019;26:663–671. doi:10.1007/s12282-019-00966-330989585
   PubMed Web of Science ®Google Scholar
• LiuY, ZhangJ, XingC, WeiS, GuoN, WangY. miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1. Cancer Biomark. 2018;23:269–277. doi:10.3233/CBM-18152730103304
   PubMed Web of Science ®Google Scholar
• RangZ, YangG, WangYW, CuiF. miR-542-3p suppresses invasion and metastasis by targeting the proto-oncogene serine/threonine protein kinase, PIM1, in melanoma. Biochem Biophys Res Commun. 2016;474:315–320. doi:10.1016/j.bbrc.2016.04.09327107696
   PubMed Web of Science ®Google Scholar
• NaitoS, von EschenbachAC, GiavazziR, FidlerIJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986;46:4109–4115.3731078
   PubMed Web of Science ®Google Scholar
• XuY, PanS, ChenH, QianH, WangZ, ZhuX. MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer. Am J Cancer Res. 2021;11:1446–1462.33948367
   PubMed Web of Science ®Google Scholar
• HuangG, LiL, LiangC, et al. Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway. Pharmacol Res Perspect. 2021;9:e00720. doi:10.1002/prp2.72033565716
   PubMed Web of Science ®Google Scholar
• AtanasovAG, ZotchevSB, DirschVM. International Natural Product Sciences T, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200–216. doi:10.1038/s41573-020-00114-z33510482
   PubMed Web of Science ®Google Scholar
• NewmanDJ, CraggGM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83:770–803. doi:10.1021/acs.jnatprod.9b0128532162523
   PubMed Web of Science ®Google Scholar
• SalehiB, VaroniEM, Sharifi-RadM, et al. Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis. Phytomedicine. 2019;55:125–136. doi:10.1016/j.phymed.2018.07.00130668422
   PubMed Web of Science ®Google Scholar
• LeeJH, ChinnathambiA, AlharbiSA, ShairOHM, SethiG, AhnKS. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway. Pharmacol Res. 2019;150:104504. doi:10.1016/j.phrs.2019.10450431678208
   PubMed Web of Science ®Google Scholar
• WangJR, ShenGN, LuoYH, et al. 2-(4-methoxyphenylthio)-5,8-dimethoxy-1,4-naphthoquinone induces apoptosis via ROS-mediated MAPK and STAT3 signaling pathway in human gastric cancer cells. J Chemother. 2019;31:214–226. doi:10.1080/1120009X.2019.161083231074342
   PubMed Web of Science ®Google Scholar
• TsangNY, ChikWI, SzeLP, WangMZ, TsangSW, ZhangHJ. The Use of Naphthoquinones and Furano-naphthoquinones as Antiinvasive Agents. Curr Med Chem. 2018;25:5007–5056. doi:10.2174/092986732466617100613192728990521
   PubMed Web of Science ®Google Scholar
• LeungMS, ChanKK, DaiWJ, et al. Anti-tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma. J Pathol. 2020;252:65–76. doi:10.1002/path.549232558942
   PubMed Web of Science ®Google Scholar
• LeungCO, WongCC, FanDN, et al. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Oncotarget. 2015;6:10880–10892. doi:10.18632/oncotarget.353425834102
   PubMedGoogle Scholar
• PeltolaK, HollmenM, MaulaSM, et al. Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor. Neoplasia. 2009;11:629–636. doi:10.1593/neo.8103819568408
   PubMed Web of Science ®Google Scholar
• AndinaN, DidichenkoS, Schmidt-MendeJ, DahindenCA, SimonHU. Proviral integration site for Moloney murine leukemia virus 1, but not phosphatidylinositol-3 kinase, is essential in the antiapoptotic signaling cascade initiated by IL-5 in eosinophils. J Allergy Clin Immunol. 2009;123:603–611. doi:10.1016/j.jaci.2008.12.00419152965
   PubMed Web of Science ®Google Scholar
• ChengJT, WangL, WangH, et al. Insights into biological role of LncRNAs in epithelial-mesenchymal transition. Cells. 2019;1:8.
   Google Scholar